Investigational Therapy Earns Orphan Drug Designation for Hereditary Angioedema
According to a story from Business Wire, the biopharmaceutical company Astria Therapeutics, Inc., recently announced that its experimental therapy navenibart has earned the US Food and Drug Administration's Orphan Drug…